Expression, purification and characterisation of recombinant Escherichia coli derived chicken interleukin-12

Veterinary Immunology and Immunopathology

Volumn 126, Issue 3-4, 2008, Pages 403-406

  Thomas, Jesse D ^a,b,c   Morris, Kirsten R ^a   Godfrey, Dale I ^c   Lowenthal, John W ^a   Bean, Andrew G D ^a  

^a CSIRO   (Australia)

^b UNIVERSITY OF NEW ENGLAND   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Chicken; Interleukin 12; Prokaryotic expression

Indexed keywords

CHICKEN INTERLEUKIN 12; DETERGENT; ISOPROPYL THIOGALACTOSIDE; NICKEL; RECOMBINANT INTERLEUKIN 12; UNCLASSIFIED DRUG; ZWITTERGENT DETERGENT;

AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; AVIAN INFLUENZA; BACTERIAL STRAIN; BIOLOGICAL ACTIVITY; CELL PROLIFERATION; CLONING VECTOR; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENTIATION; ESCHERICHIA COLI; EXPRESSION VECTOR; GENE; GENE OVEREXPRESSION; GENETIC TRANSFORMATION; IN VITRO STUDY; IN VIVO STUDY; INFLUENZA VIRUS A H5N1; LYMPHOCYTE PROLIFERATION; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTEIN PURIFICATION; SOLUBILIZATION; T LYMPHOCYTE;

ANIMALS; CHICKENS; CHROMATOGRAPHY, AFFINITY; CLONING, MOLECULAR; ESCHERICHIA COLI; GENETIC VECTORS; INTERLEUKIN-12; ISOPROPYL THIOGALACTOSIDE;

ANIMALIA; AVES; ESCHERICHIA COLI; MAMMALIA; PROKARYOTA; VERTEBRATA;

EID: 56349106013     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2008.08.004     Document Type: Article

References (22)

1. Anderson E.J., McGrath M.A., Thalhamer T., and McInnes I.B. Interleukin-12 to interleukin 'infinity': the rationale for future therapeutic cytokine targeting. Springer Semin. Immunopathol. 27 (2006) 425-442
2. Baneyx F. Recombinant protein expression in Escherichia coli. Curr. Opin. Biotechnol. 10 (1999) 411-421
3. Bliss J., Maylor R., Stokes K., Murray K.S., Ketchum M.A., and Wolf S.F. Interleukin-12 as vaccine adjuvant. Characteristics of primary, recall, and long-term responses. Ann. N.Y. Acad. Sci. 795 (1996) 26-35
4. Chehimi J., Paganin C., Frank I., Chouaib S., Starr S., and Trinchieri G. Interleukin-12 in the pathogenesis and therapy of HIV disease. Res. Immunol. 146 (1995) 605-614
5. Choi K.D., and Lillehoj H.S. Role of chicken IL-2 on gammadelta T-cells and Eimeria acervulina-induced changes in intestinal IL-2 mRNA expression and gammadelta T-cells. Vet. Immunol. Immunopathol. 73 (2000) 309-321
6. Degen W.G., van Daal N., van Zuilekom H.I., Burnside J., and Schijns V.E. Identification and molecular cloning of functional chicken IL-12. J. Immunol. 172 (2004) 4371-4380
7. Dyson M.R., Shadbolt S.P., Vincent K.J., Perera R.L., and McCafferty J. Production of soluble mammalian proteins in Escherichia coli: identification of protein features that correlate with successful expression. BMC Biotechnol. 4 (2004) 32
8. Gately M.K., Wolitzky A.G., Quinn P.M., and Chizzonite R. Regulation of human cytolytic lymphocyte responses by interleukin-12. Cell Immunol. 143 (1992) 127-142
9. Gubler U., Chua A.O., Schoenhaut D.S., Dwyer C.M., McComas W., Motyka R., Nabavi N., Wolitzky A.G., Quinn P.M., Familletti P.C., et al. Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 4143-4147
10. Hilton L.S., Bean A.G., Kimpton W.G., and Lowenthal J.W. Interleukin-2 directly induces activation and proliferation of chicken T cells in vivo. J. Interferon Cytokine Res. 22 (2002) 755-763
11. Hunt I. From gene to protein: a review of new and enabling technologies for multi-parallel protein expression. Protein Expr. Purif. 40 (2005) 1-22
12. Kobayashi M., Fitz L., Ryan M., Hewick R.M., Clark S.C., Chan S., Loudon R., Sherman F., Perussia B., and Trinchieri G. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170 (1989) 827-845
13. Lowenthal J.W., Digby M.R., and York J.J. Production of interferon-gamma by chicken T cells. J. Interferon Cytokine Res. 15 (1995) 933-938
14. Lowenthal J.W., O'Neil T.E., David A., Strom G., and Andrew M.E. Cytokine therapy: a natural alternative for disease control. Vet. Immunol. Immunopathol. 72 (1999) 183-188
15. Ma X., and Trinchieri G. Regulation of interleukin-12 production in antigen-presenting cells. Adv. Immunol. 79 (2001) 55-92
16. Micallef M.J., Ohtsuki T., Kohno K., Tanabe F., Ushio S., Namba M., Tanimoto T., Torigoe K., Fujii M., Ikeda M., Fukuda S., and Kurimoto M. Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-gamma production. Eur. J. Immunol. 26 (1996) 1647-1651
17. Nunberg J.H., Doyle M.V., York S.M., and York C.J. Interleukin 2 acts as an adjuvant to increase the potency of inactivated rabies virus vaccine. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 4240-4243
18. Presky D.H., Yang H., Minetti L.J., Chua A.O., Nabavi N., Wu C.Y., Gately M.K., and Gubler U. A functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunits. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 14002-14007
19. Robinson D., Shibuya K., Mui A., Zonin F., Murphy E., Sana T., Hartley S.B., Menon S., Kastelein R., Bazan F., and O'Garra A. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NFkappaB. Immunity 7 (1997) 571-581
20. Shen H., Li C., Lin M., Zhang Z., and Shen Q. Expression of human interleukin 12 (hIL-12) in insect cells. Chin. J. Biotechnol. 14 (1998) 205-212
21. Van Dyke M.W., Sirito M., and Sawadogo M. Single-step purification of bacterially expressed polypeptides containing an oligo-histidine domain. Gene 111 (1992) 99-104
22. Vita N., Magazin M., Marchese E., Lupker J., and Ferrara P. Closely related glycosylation patterns of recombinant human IL-2 expressed in a CHO cell line and natural IL-2. Lymphokine Res. 9 (1990) 67-79